Department of Newborn and Developmental Pediatrics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Department of Newborn and Developmental Pediatrics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1937-1944. doi: 10.1016/j.jtcvs.2018.05.098. Epub 2018 Jul 11.
The study objective was to evaluate the association of oral acetaminophen therapy versus immediate surgical ligation with neonatal outcomes in infants with persistent patent ductus arteriosus.
We performed a retrospective cohort study of preterm infants born 28 weeks or less gestational age with persistent large patent ductus arteriosus being considered for surgical ligation after unsuccessful medical therapy. Infants in epoch 1 (July 2009 to June 2012) were immediately referred for ligation, and infants in epoch 2 (July 2012 to June 2015) were treated with oral acetaminophen and referred for ligation in the absence of improvement. The primary outcome was a composite of death or chronic lung disease.
A total of 92 infants with median (interquartile range) gestational age 25.2 weeks (24.4-26.3) had persistent large patent ductus arteriosus (43 in epoch 1, 49 in epoch 2). Infants in epoch 2 had decreased surgical ligation (26 [53%] vs 31 [72%]; adjusted odds ratio [aOR], 0.32; 95% confidence interval [CI], 0.12-0.89) but increased chronic lung disease (36 [73%] vs 25 [58%]; aOR, 3.34; 95% CI, 1.05-10.58) and increased death/chronic lung disease of borderline significance (39 [80%] vs 29 [67%]; aOR, 3.09; 95% CI, 0.99-9.63). Infants in epoch 2 took longer to wean off of positive pressure ventilation (28.5 vs 24 days after enrollment; aOR, 0.52; 95% CI, 0.31-0.85).
Late oral acetaminophen therapy for infants with persistent patent ductus arteriosus is associated with reduced surgical ligation but increased chronic lung disease. In light of a lack of improvement in clinical outcomes, the individual contributory effects of acetaminophen, surgical ligation, and prolonged exposure to patent ductus arteriosus require further study to define the optimal approach.
本研究旨在评估口服扑热息痛治疗与新生儿持续性动脉导管未闭即刻手术结扎的效果,以评估其对新生儿结局的影响。
我们进行了一项回顾性队列研究,纳入了胎龄 28 周或以下的早产儿,这些早产儿存在持续性大的动脉导管未闭,且在不成功的药物治疗后考虑进行手术结扎。第 1 个时期(2009 年 7 月至 2012 年 6 月)的婴儿立即被转介进行结扎,而第 2 个时期(2012 年 7 月至 2015 年 6 月)的婴儿则在未改善的情况下接受口服扑热息痛治疗,并转介进行结扎。主要结局是死亡或慢性肺病的复合结局。
共有 92 名婴儿的中位(四分位距)胎龄为 25.2 周(24.4-26.3),存在持续性大的动脉导管未闭(第 1 个时期 43 例,第 2 个时期 49 例)。第 2 个时期手术结扎的比例降低(26[53%]例 vs 31[72%]例;调整后的优势比[aOR],0.32;95%置信区间[CI],0.12-0.89),但慢性肺病的比例增加(36[73%]例 vs 25[58%]例;aOR,3.34;95% CI,1.05-10.58),死亡/慢性肺病的比例接近显著增加(39[80%]例 vs 29[67%]例;aOR,3.09;95% CI,0.99-9.63)。第 2 个时期的婴儿需要更长的时间才能脱离正压通气(入组后 28.5 天 vs 24 天;aOR,0.52;95% CI,0.31-0.85)。
对于持续性动脉导管未闭的婴儿,晚期口服扑热息痛治疗与手术结扎减少有关,但与慢性肺病增加有关。鉴于临床结局没有改善,扑热息痛、手术结扎和动脉导管未闭持续暴露的单独影响需要进一步研究,以确定最佳方法。